| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |